Zyprexa

4 Stories

Behavioral Drugs May Triple Kids' Risk of Diabetes
Behavioral Drugs May Triple Kids' Risk of Diabetes
STUDY SAYS

Behavioral Drugs May Triple Kids' Risk of Diabetes

Anti-psychotics cause weight gain, increased insulin resistance: study

(Newser) - Anti-psychotic drugs, used to treat behavioral disorders in children, may actually be tripling their risk of developing type 2 diabetes. Those who took Abilify, Risperdal, Seroquel, and Zyprexa were three times more at risk than those who took other drugs for the same issues, USA Today reports, via a 12-year...

Antipsychotic Drugs Triple Health Risks in Elderly

Dementia research finds even brief use is dangerous

(Newser) - Elderly dementia patients given antipsychotic drugs, even briefly, are three times as likely to end up hospitalized or dead within a month, new research has found. The study looked at 40,000 elderly Canadians, half of them in nursing homes, and found that the drugs increased the risk of...

Eli Lilly Could Pay $1B Settlement
Eli Lilly Could Pay $1B Settlement

Eli Lilly Could Pay $1B Settlement

Fine for illegally promoting antipsychotic drug Zyprexa would be biggest ever

(Newser) - Drug-maker Eli Lilly could pay more than $1 billion to state and federal authorities to settle an investigation into how the company marketed an antipsychotic drug, the New York Times reports. In 2000-03, Lilly pushed doctors to prescribe Zyprexa as a treatment for age-related dementia—though the drug is approved...

Big Pharma Faces Big Plunge
Big Pharma Faces Big Plunge

Big Pharma Faces Big Plunge

Profits will drop as patents expire, and chemical-based therapies are eclipsed by biotech

(Newser) - Patent protections on some of the pharmaceutical industry's best-selling drugs, like Lipitor, Plavix and Singulair, are due to expire in the next several years, and drug manufacturers have little in the pipeline to replace them. The drug companies will lose billions—as much as half their combined revenue—to generic...

4 Stories
Most Read on Newser